US 12,115,357 B2
Integrated delivery device for continuous glucose sensor
James H. Brauker, Addison, MI (US); Mark A. Tapsak, Orangeville, PA (US); Sean T. Saint, San Diego, CA (US); Apurv Ullas Kamath, San Diego, CA (US); Paul V. Neale, San Diego, CA (US); Peter C. Simpson, Cardiff, CA (US); Michael Robert Mensinger, San Diego, CA (US); and Dubravka Markovic, San Diego, CA (US)
Assigned to DEXCOM, INC., San Diego, CA (US)
Filed by DexCom, Inc., San Diego, CA (US)
Filed on Mar. 16, 2022, as Appl. No. 17/696,198.
Application 12/536,852 is a division of application No. 10/789,359, filed on Feb. 26, 2004, granted, now 7,591,801, issued on Sep. 22, 2009.
Application 17/696,198 is a continuation of application No. 17/556,761, filed on Dec. 20, 2021.
Application 17/556,761 is a continuation of application No. 15/906,946, filed on Feb. 27, 2018, granted, now 11,246,990.
Application 15/906,946 is a continuation of application No. 14/830,568, filed on Aug. 19, 2015, granted, now 9,937,293, issued on Apr. 10, 2018.
Application 14/830,568 is a continuation of application No. 13/559,454, filed on Jul. 26, 2012, granted, now 9,155,843, issued on Oct. 13, 2015.
Application 13/559,454 is a continuation of application No. 13/180,396, filed on Jul. 11, 2011, granted, now 8,460,231, issued on Jun. 11, 2013.
Application 13/180,396 is a continuation of application No. 12/536,852, filed on Aug. 6, 2009, granted, now 7,976,492, issued on Jul. 12, 2011.
Prior Publication US 2022/0203038 A1, Jun. 30, 2022
Int. Cl. A61M 5/315 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61B 5/1486 (2006.01); A61M 5/172 (2006.01); A61M 11/00 (2006.01); A61M 15/00 (2006.01); G16H 10/40 (2018.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01)
CPC A61M 5/31525 (2013.01) [A61B 5/0002 (2013.01); A61B 5/14532 (2013.01); A61B 5/14865 (2013.01); A61B 5/4839 (2013.01); A61M 5/1723 (2013.01); A61M 11/00 (2013.01); A61M 15/0001 (2014.02); G16H 10/40 (2018.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); A61B 5/1486 (2013.01); A61B 2560/0443 (2013.01); A61M 2005/1726 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2230/201 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of operating a medicament delivery device capable of administering a medicament to a patient, the method comprising:
obtaining, by a receiver associated with the medicament delivery device, measured analyte values indicative of an analyte concentration of the patient provided by an analyte sensor;
identifying, by the receiver, occurrence of a learned pattern of the patient based on the measured analyte values of the analyte concentration over time;
providing, by the receiver, a user interface indicating the identified pattern; and
in response to receiving a user validation that is required under conditions that are learned based on the identified pattern, adjusting, by the receiver, operation of the medicament delivery device to administer the medicament to the patient based on the identified pattern.